Annkathrin Hanssen
Overview
Explore the profile of Annkathrin Hanssen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schneegans S, Loptien J, Mojzisch A, Loreth D, Kretz O, Raschdorf C, et al.
J Exp Clin Cancer Res
. 2024 Apr;
43(1):110.
PMID: 38605423
Background: Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal...
2.
Riebensahm C, Joosse S, Mohme M, Hanssen A, Matschke J, Goy Y, et al.
Breast Cancer Res
. 2019 Sep;
21(1):101.
PMID: 31481116
Background: The incidence of brain metastases in breast cancer (BCBM) patients is increasing. These patients have a very poor prognosis, and therefore, identification of blood-based biomarkers, such as circulating tumor...
3.
Scharpenseel H, Hanssen A, Loges S, Mohme M, Bernreuther C, Peine S, et al.
Sci Rep
. 2019 May;
9(1):7406.
PMID: 31092882
Although clinically relevant, the detection rates of EpCAM positive CTCs in non-small cell lung cancer (NSCLC) are surprisingly low. To find new clinically informative markers for CTC detection in NSCLC,...
4.
Hanssen A, Riebensahm C, Mohme M, Joosse S, Velthaus J, Berger L, et al.
Cancers (Basel)
. 2018 Dec;
10(12).
PMID: 30572662
Forty percent of non-small cell lung cancer (NSCLC) patients develop brain metastases, resulting in a dismal prognosis. However, patients in an oligo-metastatic brain disease setting seem to have better outcomes....
5.
Berger L, Janning M, Velthaus J, Ben-Batalla I, Schatz S, Falk M, et al.
J Thorac Oncol
. 2018 Sep;
13(12):e243-e246.
PMID: 30205165
No abstract available.
6.
Effenberger K, Schroeder C, Hanssen A, Wolter S, Eulenburg C, Tachezy M, et al.
Clin Cancer Res
. 2018 Mar;
24(12):2844-2850.
PMID: 29559560
Pancreatic cancer is one of the most devastating diseases with a 5-year survival rate of 3% to 5%. Here, we investigated whether circulating tumor cells (CTC) may predict metastatic spread...
7.
Hanssen A, Wagner J, Gorges T, Taenzer A, Uzunoglu F, Driemel C, et al.
Sci Rep
. 2016 Jun;
6:28010.
PMID: 27302574
Circulating tumour cells (CTCs) serve as valuable biomarkers. However, EpCAM positive CTCs are less frequently detected in NSCLC patients compared to other epithelial tumours. First, EpCAM protein expression was analysed...
8.
Hanssen A, Loges S, Pantel K, Wikman H
Front Oncol
. 2015 Oct;
5:207.
PMID: 26442219
Lung cancer is the most common cause of cancer-related deaths that frequently metastasizes prior to disease diagnosis. Circulating tumor cells (CTCs) are found in many different types of epithelial tumors...
9.
Uzunoglu F, Dethlefsen E, Hanssen A, Wrage M, Deutsch L, Harms-Effenberger K, et al.
PLoS One
. 2014 Dec;
9(12):e113315.
PMID: 25501003
This study was performed to assess the prognostic relevance of genomic aberrations at chromosome 4q in NSCLC patients. We have previously identified copy number changes at 4q12-q32 to be significantly...